Publications by authors named "D Launay"

Introduction: Inflammatory bowel diseases (IBDs) are chronic immune driven intestinal disorders with marked metabolic alteration. Mass spectrometry imaging (MSI) enables the direct visualization of biomolecules within tissues and facilitates the study of metabolic changes. Integrating multiple spatial information sources is a promising approach for discovering new biomarkers and understanding biochemical alteration within the context of the disease.

View Article and Find Full Text PDF

Background And Aims: Systemic sclerosis (SSc) is an autoimmune connective disease characterised by excessive extracellular matrix deposition and widespread skin and internal organ fibrosis including various cardiac manifestations. Heart involvement is one of the leading causes of death among patients with SSc. In this study, we aimed to assess the effect of various vasodilator treatments.

View Article and Find Full Text PDF
Article Synopsis
  • Systemic sclerosis (SSc) is a rare autoimmune disease classified into two groups based on skin involvement; this study investigates the role of autoantibody profiles in predicting organ damage and mortality compared to skin phenotype.
  • Researchers analyzed data from 1,605 patients across seven French hospitals, focusing on autoantibodies and their correlation with various organ issues and death rates.
  • Findings reveal that specific autoantibodies are strongly linked to serious complications like interstitial lung disease and renal crisis, while skin phenotype alone does not effectively predict patient outcomes.
View Article and Find Full Text PDF

Janus kinase (JAK) molecules are involved in important cellular activation pathways. Over the past decade, many targeted therapies have emerged, including the increasingly promising role of JAK inhibitors (JAKi) in the treatment of inflammatory and autoimmune diseases. The spectrum of use of these small molecules is increasingly broader.

View Article and Find Full Text PDF
Article Synopsis
  • Anemia is common in systemic sclerosis patients, with 20% of those studied being affected, primarily due to iron deficiency.
  • The study revealed that patients with anemia had more severe symptoms and higher mortality rates compared to those with normal hemoglobin levels, indicating a significant impact on prognosis.
  • Researchers suggest that further investigation is needed to understand the underlying causes of anemia and its effects on systemic sclerosis outcomes.
View Article and Find Full Text PDF